Back
Entrada Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
33
TRDA
Entrada Therapeutics
Last Price:
$6.54
Seasonality Move:
15.76%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.
Entrada Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.08 | Sell |
20-day SMA: | 7.13 | Sell |
50-day SMA: | 7.79 | Sell |
200-day SMA: | 12.78 | Sell |
8-day EMA: | 4.39 | Buy |
20-day EMA: | 2.3 | Buy |
50-day EMA: | 1.03 | Buy |
200-day EMA: | 0.27 | Buy |
Entrada Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.54 | Buy |
Relative Strength Index (14 RSI): | 37.36 | Sell |
Chaikin Money Flow: | -134459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.84 - 7.82) | Sell |
Bollinger Bands (100): | (7.22 - 10.56) | Sell |
Entrada Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
-
Entrada Therapeutics share price is 6.55 while TRDA 8-day simple moving average is 7.08, which is a Sell signal.
-
The stock price of TRDA is 6.55 while Entrada Therapeutics 20-day SMA is 7.13, which makes it a Sell.
-
Entrada Therapeutics 50-day simple moving average is 7.79 while TRDA share price is 6.55, making it a Sell technically.
-
TRDA stock price is 6.55 and Entrada Therapeutics 200-day simple moving average is 12.78, creating a Sell signal.
TRDA Technical Analysis vs Fundamental Analysis
Sell
33
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a SellThe current Entrada Therapeutics [TRDA] share price is $6.55. The Score for TRDA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
248.6M
Price in USD:
6.55
Share Volume:
220K
Entrada Therapeutics 52-Week Range
52-Week High:
21.79
52-Week Low:
6.48
Sell
33
Entrada Therapeutics (TRDA)
is a Sell
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?The Entrada Therapeutics stock price is 6.55 USD today.
-
Will TRDA stock go up or go down?Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Entrada Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is overvalued.
Is Entrada Therapeutics Stock a Buy?
-
Entrada Therapeutics share price is 6.55 while TRDA 8-day exponential moving average is 4.39, which is a Buy signal.
-
The stock price of TRDA is 6.55 while Entrada Therapeutics 20-day EMA is 2.30, which makes it a Buy.
-
Entrada Therapeutics 50-day exponential moving average is 1.03 while TRDA share price is 6.55, making it a Buy technically.
-
TRDA stock price is 6.55 and Entrada Therapeutics 200-day simple moving average is 0.27, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.27 per share, a decrease this year of $4.26 per share, and a decrease next year of $0.98 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
-
TRDA Moving Average Covergence Divergence (MACD) indicator is 1.54, suggesting Entrada Therapeutics is a Buy
-
Entrada Therapeutics Relative Strength Index (RSI) is 37.36, which suggest Entrada Therapeutics is oversold
-
The Bollinger Bands (25) for Entrada Therapeutics is (6.84 - 7.82), which suggest Entrada Therapeutics is a Sell
-
The Bollinger Bands (100) for Entrada Therapeutics is (7.22 - 10.56), which suggest Entrada Therapeutics is a Sell
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.